We found that TFH express higher levels of CD40L than non-TFH in both CLL patients and controls, however CLL TFH exhibit a strikingly elevated expression of CD40L (approximately 5-fold on average) relative to control TFH (Figure 4A). Here, CD40LG is linked to B-cell chronic lymphocytic leukemia.